Heat and Mass Transfer during the Cryopreservation of a Bioartificial Liver Device: A Computational Model

Bioartificial liver devices (BALs) have proven to be an effective bridge to transplantation for cases of acute liver failure. Enabling the long-term storage of these devices using a method such as cryopreservation will ensure their easy off the shelf availability. To date, cryopreservation of liver cells has been attempted for both single cells and sandwich cultures. This study presents the potential of using computational modeling to help develop a cryopreservation protocol for storing the three dimensional BAL: Hepatassist. The focus is upon determining the thermal and concentration profiles as the BAL is cooled from 37°C–100°C, and is completed in two steps: a cryoprotectant loading step and a phase change step. The results indicate that, for the loading step, mass transfer controls the duration of the protocol, whereas for the phase change step, when mass transfer is assumed negligible, the latent heat released during freezing is the control factor. The cryoprotocol that is ultimately proposed considers time, cooling rate, and the temperature gradients that the cellular space is exposed to during cooling. To our knowledge, this study is the first reported effort toward designing an effective protocol for the cryopreservation of a three-dimensional BAL device.

[1]  P. Mazur Cryobiology: the freezing of biological systems. , 1970, Science.

[2]  P. C. Chau,et al.  A radial flow hollow fiber bioreactor for the large‐scale culture of mammalian cells , 1986, Biotechnology and bioengineering.

[3]  L. J. Hayes,et al.  Prediction of local cooling rates and cell survival during the freezing of a cylindrical specimen. , 1988, Cryobiology.

[4]  R. Mcnally Cryopreserved bioprostheses , 1989, IEEE Engineering in Medicine and Biology Magazine.

[5]  L.E. Baker,et al.  Principles of the impedance technique , 1989, IEEE Engineering in Medicine and Biology Magazine.

[6]  John F. Carpenter,et al.  The basis for toxicity of certain cryoprotectants: A hypothesis , 1990 .

[7]  Charles L. Cooney,et al.  Nutrient and metabolite gradients in mammalian cell hollow fiber bioreactors , 1991 .

[8]  Mehmet Toner,et al.  Long-Term Functional Recovery of Hepatocytes after Cryopreservation in a Three-Dimensional Culture Configuration* , 1992, Cell transplantation.

[9]  J. White,et al.  Evaluation of a hepatocyte‐entrapment hollow fiber bioreactor: A potential bioartificial liver , 1993, Biotechnology and bioengineering.

[10]  E G Cravalho,et al.  Nucleation and growth of ice crystals inside cultured hepatocytes during freezing in the presence of dimethyl sulfoxide. , 1993, Biophysical journal.

[11]  F. Villamil,et al.  Early clinical experience with a hybrid bioartificial liver. , 1995, Scandinavian journal of gastroenterology. Supplement.

[12]  B. Solomon,et al.  Functional recovery of porcine hepatocytes after hypothermic or cryogenic preservation for liver support systems. , 1997, Cell transplantation.

[13]  H. Mizumoto,et al.  Formation of a spherical multicellular aggregate (spheroid) of animal cells in the pores of polyurethane foam as a cell culture substratum and its application to a hybrid artificial liver. , 1998, Journal of biomaterials science. Polymer edition.

[14]  P. Törmälä,et al.  Material properties of a , 2021, Practical Micromechanics of Composite Materials.

[15]  G. Jovčić,et al.  The influence of different cryopreservation protocols on the recovery and engraftment potential of hematopoietic stem and progenitor cells. , 2000 .

[16]  N. Gibran,et al.  Effect of storage and preservation methods on viability in transplantable human skin allografts. , 2000, Burns : journal of the International Society for Burn Injuries.

[17]  J L Lewis,et al.  A simple cryopreservation method for the maintenance of cell viability and mechanical integrity of a cultured cartilage analog. , 2000, Cryobiology.

[18]  S. Chevret,et al.  Comparison of the outcome of unrelated bone marrow (Bm) Or cord blood (Cb) Transplant in children with acute leukemia (Al) , 2000 .

[19]  M. Clemens,et al.  HETEROGENEOUS FLOW PATTERNS DURING HYPOTHERMIC MACHINE PERFUSION PRESERVATION OF LIVERS1 , 2000, Transplantation.

[20]  B. Solomon,et al.  Bioartificial liver treatment prolongs survival and lowers intracranial pressure in pigs with fulminant hepatic failure. , 2001, Artificial organs.

[21]  Igor M Sauer,et al.  Modular extracorporeal liver support. , 2002, Artificial organs.

[22]  P. Friend,et al.  Liver and kidney preservation by perfusion , 2002, The Lancet.

[23]  J. Bischof,et al.  Cryopreservation of Equine Sperm: Optimal Cooling Rates in the Presence and Absence of Cryoprotective Agents Determined Using Differential Scanning Calorimetry1 , 2002, Biology of reproduction.

[24]  R. McClelland,et al.  Modeling O2 transport within engineered hepatic devices. , 2003, Biotechnology and bioengineering.

[25]  P. Friend,et al.  Hepatic control of perfusate homeostasis during normothermic extrocorporeal preservation. , 2003, Transplantation proceedings.

[26]  Use of Directional Solidification to Quantify the Thermophysical Properties of DMSO-based Cryoprotectant Solutions , 2004 .